Author's posts
That Nonprofit Generic Firm Has A Name, $100 Million, And A CEO Who Will Work For Free
“We don’t think this market should be monetized,” says the chair of the board.
Why HeartFlow’s Data From This Weekend Don’t Change Anything
The $1.5 billion health-tech startup HeartFlow has a noninvasive test for heart disease based on machine learning analysis of CT scans. Two new studies are unlikely to win over its critics.
HeartFlow Has Raised $500 Million For A Test To Detect Heart Disease. Does It Make Patients Better Off?
HeartFlow has raised $467 million for a test to detect heart disease. Problem: It might not make patients better off.
His Wife’s Car Crash Changed The Way A Hospital CEO Sees His Job
She got great care in the hospital, but getting care after she was discharged was “a nightmare.”
Does Tiny Iovance Deserve To Ride The T-Cell Wave?
Right now, only one company is trying to develop a new type of cell therapy for cancer: Iovance Biotherapeutics, with a market cap of $1.3 billion and 80 employees, and $246 million in the bank.
Highly Anticipated Data On Would-Be Alzheimer’s Drug Raises Hope And Questions
Biogen’s Chief Medical Officer calls the results “a shot in the arm.” An analyst calls the noise “deafening.” A doctor sees potential help for patients.
Biogen And Eisai Present Positive Results For Experimental Alzheimer’s Drug
Drugmakers Eisai and Biogen presented positive results of their much-anticipated experimental Alzheimer’s drug BAN-2401 today at the Alzheimer’s Association International Conference in Chicago. But doctors still have questions.
Blood Pressure Drugs May Prevent Memory Problems, Study Says
“Even after only two and a half years of taking blood pressure lowering medication, this is a dramatic benefit to improve brain health, especially lowering risk for mild cognitive impairment,” says lead study author Jeff Williamson of Wake Forest Unive…
NIH Targets $500 Million At Opioid Crisis
The National Institutes of Health is explaining how it will spend $500 million in research funds Congress appropriated to address the current opioid crisis.
